A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions
- Fallopian Tube Carcinoma
- Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
- Ovarian Clear Cell Cystadenocarcinoma
- Ovarian Endometrioid Adenocarcinoma
- Ovarian Mucinous Cystadenocarcinoma
- Ovarian Serous Cystadenocarcinoma
- Primary Peritoneal Carcinoma
- Recurrent Ovarian Carcinoma
- Undifferentiated Ovarian Carcinoma
Interventions
- BIOLOGICAL: Urokinase-Derived Peptide A6
- OTHER: Laboratory Biomarker Analysis
Sponsor
Gynecologic Oncology Group
Collaborators